New Studies
Major findings from Lancet, BMJ, NEJM, JAMA, and other leading journals
First In Vivo CRISPR Gene Editing Treatment Shows Promise for Rare Blood Disorder
First clinical trial of in vivo CRISPR gene editing for hereditary angioedema shows promising results. The investigational therapy targets genetic…
Editor's Top Picks
Minocycline Stroke Trial Debate Highlights Neuroprotection Research Challenges
Scientific debate in The Lancet highlights persistent challenges in stroke neuroprotection research following criticism of the EMPHASIS minocycline trial. Researchers…
Submit Your Paper →
More form New Studies
Pediatric influenza hospitalizations nearly doubled post-pandemic, Canadian surveillance finds
Canadian surveillance study reveals pediatric influenza hospitalizations nearly doubled in 2022–2023, with age distribution shifting…
Breakthrough Drug Targeting ‘Undruggable’ KRAS Mutation Nearly Doubles Pancreatic Cancer Survival
New targeted therapy daraxonrasib successfully inhibits KRAS mutations in pancreatic cancer, nearly doubling survival times.…
Large Brazilian Study Links Table Salt Habits to Cognitive Decline in 8,300 Older Adults
A comprehensive study of 8,300 older Brazilian adults found that men are significantly more likely…
Prenatal Zika exposure linked to vision, hearing deficits despite apparently healthy births
New research reveals that infants with prenatal Zika exposure develop vision, hearing, and social deficits…
Gut Parasites May Manipulate Human Behavior, New Research Suggests
New research explores how gut parasites may influence human behavior through complex biochemical pathways. Studies…